CN105919025A - Vegetable salt containing Chinese mahogany seed extract and preparation method thereof - Google Patents
Vegetable salt containing Chinese mahogany seed extract and preparation method thereof Download PDFInfo
- Publication number
- CN105919025A CN105919025A CN201610294008.2A CN201610294008A CN105919025A CN 105919025 A CN105919025 A CN 105919025A CN 201610294008 A CN201610294008 A CN 201610294008A CN 105919025 A CN105919025 A CN 105919025A
- Authority
- CN
- China
- Prior art keywords
- tonnae sinensis
- sinensis extract
- fructus tonnae
- plant salt
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000284 extract Substances 0.000 title claims abstract description 80
- 150000003839 salts Chemical class 0.000 title claims abstract description 77
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 238000000605 extraction Methods 0.000 title claims description 19
- 241000425037 Toona sinensis Species 0.000 title abstract 8
- 235000013311 vegetables Nutrition 0.000 title abstract 5
- 241000586290 Suaeda salsa Species 0.000 claims abstract description 25
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000002137 ultrasound extraction Methods 0.000 claims abstract description 12
- 229940074391 gallic acid Drugs 0.000 claims abstract description 10
- 235000004515 gallic acid Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 17
- 229930003944 flavone Natural products 0.000 claims description 13
- 235000011949 flavones Nutrition 0.000 claims description 13
- 238000011144 upstream manufacturing Methods 0.000 claims description 13
- 239000003960 organic solvent Substances 0.000 claims description 11
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 10
- 150000002212 flavone derivatives Chemical class 0.000 claims description 10
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 102000004139 alpha-Amylases Human genes 0.000 claims description 3
- 108090000637 alpha-Amylases Proteins 0.000 claims description 3
- 229940024171 alpha-amylase Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 230000007794 irritation Effects 0.000 abstract description 8
- 241001465754 Metazoa Species 0.000 abstract description 5
- 208000019695 Migraine disease Diseases 0.000 abstract description 4
- 206010027599 migraine Diseases 0.000 abstract description 4
- 229930003935 flavonoid Natural products 0.000 abstract 2
- 150000002215 flavonoids Chemical class 0.000 abstract 2
- 235000017173 flavonoids Nutrition 0.000 abstract 2
- 235000002639 sodium chloride Nutrition 0.000 description 59
- 230000008859 change Effects 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 241000201912 Suaeda Species 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 241000223678 Aureobasidium pullulans Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000871189 Chenopodiaceae Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000235061 Pichia sp. Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000326334 Coniella diplodiella Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- 241000201920 Salicornia bigelovii Species 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000274938 Suaeda heteroptera Species 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003818 cinder Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 206010052787 migraine without aura Diseases 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides vegetable salt containing Chinese mahogany seed extract. The vegetable salt containing the Chinese mahogany seed extract comprises the following raw materials in parts by weight: 2-4 parts of Chinese mahogany seed extract and 6-8 parts of suaeda salsa vegetable-salt; the Chinese mahogany seed extract is characterized by having Chinese mahogany seed total flavonoid content of 0.53-0.61mg/g and gallic acid content of 0.42-0.53mg/g; and the suaeda salsa vegetable-salt is characterized by having total flavonoid content of 2.6-2.7mg/g and Fe content of 690-700mg/g. The invention further provides a preparation method of the vegetable salt containing the Chinese mahogany seed extract. The preparation method comprises a step of carrying out continuous countercurrent tube-type ultrasonic extraction. The vegetable salt containing the Chinese mahogany seed extract prepared by the preparation method has the effects of treating migraine, and is free of local irritation to animals.
Description
Technical field
The present invention relates to a kind of plant salt containing Fructus Tonnae Sinensis extract and preparation method thereof, belong to plant salt extraction process technology field.
Background technology
Fructus Tonnae Sinensis, warm in nature, acrid in the mouth is bitter, nontoxic, enters liver, lung meridian, and tool dispels the wind, cold expelling, analgesic efficacy, cures mainly wind and cold diseases caused by exogenous pathogenic factor, heart peratodynia, rheumatic arthritis, hernia etc..Tonnae Sinensis is distributed in the ground such as North China, northwest, southwest, East China, especially with Shandong, Hebei two province is for many.Tonnae Sinensis, to plant at most, adds widely distributed wild Tonnae Sinensis, and overall resource is the abundantest.The area such as Linyi, Shandong Province, Liaocheng masses use Fructus Tonnae Sinensis soaked or decoction, have good therapeutic effect to DN, belong to medication among the people.
Tonnae Sinensis is that a kind of purposes is relatively wide, abundance, with low cost, the plant of medicine-food two-purpose, there is good value of exploiting and utilizing.Have now been found that Fructus Tonnae Sinensis has blood sugar lowering, antioxidation, anticoagulation, antithrombotic, raising fibrinolytic, Ischemic myocardium reperfusion injury, improves the effect such as endotheliocyte of the blood stream rheology of myocardial ischemia-reperfusion, protection neurocyte, protection activation and damage.
Sal edible is the important ladder of human progress, and the mankind rely on sea water to evaporate brine and the method such as well salt, rock salt mining manufactures Sal for a long time, meet self-demand.But the salt that the mankind are eaten for a long time is substantially inorganic matter, the human body self demand to inorganic salt can only be met, it is difficult in adapt to owing to living standard promotes the mankind the caused demand to several functions food, Sal is essentially sodium chloride the most in the market, and too high Na+ takes in the blood pressure to human body, blood fat etc. all significantly negative effect.
Based on case above, current India takes the lead in utilizing Salicornia Bigelovii Torr. to produce plant salt in the world, it was reported that this plant salt, rich in trace element such as potassium, calcium, magnesium, ferrum, without adding any chemical substance in the course of processing, therefore can be rated as " natural nutritive salt ".
Suaeda salsa is annual herb salification plant, botany classification is Chenopodiaceae (chenopodiaceae) Suaeda (suaedaforsk.exscop), primary growth in beach, the saline-alkali wasteland of lakeside, desert etc., it is a kind of typical salt-soda soil indicator plant, has in the varieties in saline-alkali areas of Sea And Bohai Sea Coast and the ground such as Xinjiang, Inner Mongol and be distributed widely.China has 20 kinds and 1 mutation of Suaeda plant, and Common Species is grayish green Herba suadeae glaucae (suaeda.glancabunge) and Suaeda salsa (S.salsa (L.) Pall), and what yield was maximum is grayish green Herba suadeae glaucae.Research to Suaeda plant at present is concentrated mainly on grayish green Herba suadeae glaucae, Suaeda salsa and Suaeda heteroptera.
Suaeda salsa is one of herbaceous plant that salinity is the highest in the world, and total salt quantity is up to 4.54%.In anion, Cl-accounts for the 47.14% of total salt, in cation, Mg2+Account for the 20.04% of total salt, outside this external fat, protein, the rich content of mineral, trace element and vitamin, it is adapted for plant salt production development, but this problem not yet is given fully to pay attention to by presently relevant department.Such as beach and wetland that Sea And Bohai Sea Coast area, Tianjin major part is high salt basicity, easily it is suitable for the growth of Herba suadeae glaucae.For a long time, these Herba suadeae glaucae run its course, and never cause the enough attention of people.
There is following defect in prior art:
(1) plant salt prepared by existing technique is big to animal local irritation；
(2) plant salt prepared by the existing technique DeGrain in treatment migraine；
(3) plant salt prepared by existing technique, the extracted amount of gallic acid is the highest；
(4) plant salt prepared by existing technique, the yield of total flavones is the highest.
Summary of the invention
The present invention solves above technical problem, it is provided that a kind of plant salt containing Fructus Tonnae Sinensis extract and preparation method thereof, to realize following goal of the invention:
(1) plant salt containing Fructus Tonnae Sinensis extract prepared by the present invention, to experimental animal without obvious local irritation.
(2) plant salt containing Fructus Tonnae Sinensis extract prepared by the present invention, has the migrainous effect for the treatment of.
(3) preparation method of the present invention plant salt containing Fructus Tonnae Sinensis extract, in the preparation method of Fructus Tonnae Sinensis extract, the extraction content of gallic acid is high.
(4) preparation method of the present invention plant salt containing Fructus Tonnae Sinensis extract, in the preparation method of Fructus Tonnae Sinensis extract, the yield of total flavones is high.
For solving above technical problem, the technical solution used in the present invention is as follows:
A kind of plant salt containing Fructus Tonnae Sinensis extract, described plant salt, raw material includes Fructus Tonnae Sinensis extract and Suaeda salsa plant salt.
The following is and the further of technique scheme is improved:
Described plant salt, including the raw material of following weight portion: Fructus Tonnae Sinensis extract 2 ~ 4 parts, Suaeda salsa plant salt 6 ~ 8 parts.
Described Fructus Tonnae Sinensis extract, Fructus Tonnae Sinensis general flavone content is 0.53 ~ 0.61mg/g, and gallic acid content is 0.42 ~ 0.53mg/g.
Described Suaeda salsa plant salt, general flavone content be 2.6 ~ 2.7mg/g, Fe content be 690 ~ 700mg/kg.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract, the preparation of described Fructus Tonnae Sinensis extract includes continuous flow upstream tubular ultrasonic extraction step, described continuous flow upstream tubular ultrasonic extraction step, the charging rate 0.5 ~ 3.5kg/min of Fructus Tonnae Sinensis superfine powder.
The preparation of described Fructus Tonnae Sinensis extract includes continuous flow upstream tubular ultrasonic extraction step, described continuous flow upstream tubular ultrasonic extraction step, organic solvent reverse flow velocity 6 ~ 12L/min.
Described continuous flow upstream tubular ultrasonic extraction step, supersound extraction pipe temperature 55 ~ 85 DEG C.
The preparation of described Fructus Tonnae Sinensis extract also includes breaking cellular wall step, described breaking cellular wall step, under vacuum is-0.073MPa～-0.08MPa, and microwave treatment 10～30min.
The preparation of described Fructus Tonnae Sinensis extract also includes concentrating under reduced pressure step, described concentrating under reduced pressure step, and decompressed pressure is 0.08 ~ 0.1MPa.
Described Suaeda salsa plant salt extraction step includes enzymolysis process, and described enzymolysis process, in Herba suadeae glaucae mass ratio 3～the ratio addition α-amylase of 5%, hydrolysis temperature 70～80 DEG C.
Use above technical scheme, the invention have the benefit that
(1) present invention plant salt containing Fructus Tonnae Sinensis extract, to experimental animal without obvious local irritation, give in the 1mg/ml of the SD rats with bilateral nasal cavity collunarium present invention solution 1.5ml/kgbw4h that the plant salt containing Fructus Tonnae Sinensis extract is made into, the outward appearance of rat, behavioral activity, the mental status, two just and color, breath state, nose, eye, oral cavity secretions the most without exception, through histopathological examination, it is showed no significantly damage change and a large amount of cell infiltration.
(2) present invention plant salt containing Fructus Tonnae Sinensis extract, it is possible to treatment migraine, gives the migraine patient 10mg/d present invention plant salt containing Fructus Tonnae Sinensis extract 4 weeks, and headache and the effective percentage that simultaneous phenomenon substantially alleviates, attack times reduces are 91.11 ~ 94.44%；The effective percentage of matched group is 57.58%.
(3) preparation method of the present invention plant salt containing Fructus Tonnae Sinensis extract, in the preparation method of Fructus Tonnae Sinensis extract, the extraction content of gallic acid is high, and gallic acid content is 0.42 ~ 0.53mg/g.
(4) preparation method of the present invention plant salt containing Fructus Tonnae Sinensis extract, in the preparation method of Fructus Tonnae Sinensis extract, the yield of total flavones is high, yield 6.2 ~ 6.6%.
Detailed description of the invention
Hereinafter the preferred embodiments of the present invention are illustrated, it will be appreciated that preferred embodiment described herein is merely to illustrate and explains the present invention, is not intended to limit the present invention.
Embodiment
1
A kind of plant salt containing Fructus Tonnae Sinensis extract
In parts by weight, including following raw material components:
Fructus Tonnae Sinensis extract 4 parts, Suaeda salsa plant salt 6 parts.
Described Fructus Tonnae Sinensis extract, density is 1.71 ~ 1.82g/cm3, Fructus Tonnae Sinensis general flavone content is 0.53 ~ 0.61mg/g, and Fructus Tonnae Sinensis polyphenol content is 3.54 ~ 3.47mg/g, and gallic acid content is 0.42 ~ 0.53mg/g.
Described Suaeda salsa plant salt, sodium content is 15.20 ~ 15.30%；Potassium content is 3.4 ~ 3.5%；General flavone content is 2.6 ~ 2.7mg/g；Ca content is 2600 ~ 2700mg/kg；Fe content is 690 ~ 700mg/kg.
Embodiment
2
A kind of plant salt containing Fructus Tonnae Sinensis extract
In parts by weight, including following raw material components:
Fructus Tonnae Sinensis extract 3 parts, Suaeda salsa plant salt 7 parts.
Described Fructus Tonnae Sinensis extract, density is 1.71 ~ 1.82g/cm3, Fructus Tonnae Sinensis general flavone content is 0.53 ~ 0.61mg/g, and Fructus Tonnae Sinensis polyphenol content is 3.54 ~ 3.47mg/g, and gallic acid content is 0.42 ~ 0.53mg/g.
Described Suaeda salsa plant salt, sodium content is 15.20 ~ 15.30%；Potassium content is 3.4 ~ 3.5%；General flavone content is 2.6 ~ 2.7mg/g；Ca content is 2600 ~ 2700mg/kg；Fe content is 690 ~ 700mg/kg.
Embodiment
3
A kind of plant salt containing Fructus Tonnae Sinensis extract
In parts by weight, including following raw material components:
Fructus Tonnae Sinensis extract 2 parts, Suaeda salsa plant salt 8 parts.
Described Fructus Tonnae Sinensis extract, density is 1.71 ~ 1.82g/cm3, Fructus Tonnae Sinensis general flavone content is 0.53 ~ 0.61mg/g, and Fructus Tonnae Sinensis polyphenol content is 3.54 ~ 3.47mg/g, and gallic acid content is 0.42 ~ 0.53mg/g.
Described Suaeda salsa plant salt, sodium content is 15.20 ~ 15.30%；Potassium content is 3.4 ~ 3.5%；General flavone content is 2.6 ~ 2.7mg/g；Ca content is 2600 ~ 2700mg/kg；Fe content is 690 ~ 700mg/kg.
Embodiment
4
A kind of preparation method of Fructus Tonnae Sinensis extract
Comprise the following steps:
(
1
) ultrasonic grinding
Weighing dry Fructus Tonnae Sinensis, pulverize, cross 60 ~ 80 mesh sieves, ratio 1mmol/L by weight 1: 50, pH are the PBS immersion 40 ~ 60min of 6.8, the most swelling；
In ice bath, carry out cell breakage with the ultrasonic echography 15 ~ 19min of power 750 ~ 820W, be crushed to 0.5 ~ 2.5 μm, obtain crude extract.
Water content≤10% of described dry Fructus Tonnae Sinensis.
(
2
) breaking cellular wall
Crude extract is carried out low-temperature airflow broken wall treatment, obtains Fructus Tonnae Sinensis superfine powder.
Described low-temperature airflow breaking cellular wall is that low-temperature vacuum microwave processes；
Described low-temperature vacuum microwave is processed as microwave treatment 10～30min under vacuum；
Described vacuum condition be vacuum be-0.073MPa～-0.08MPa.
(
3
) extraction of continuous flow upstream tubular ultrasonic
By Fructus Tonnae Sinensis superfine powder, in 0.5kg/min speed input continuous flow upstream tubular ultrasonic extractor, inversely to input organic solvent with 6L/min flow velocity, to keep supersound extraction pipe temperature 55 DEG C, to extract 45 ~ 55min, obtain Fructus Tonnae Sinensis organic solvent extraction mixture；
Fructus Tonnae Sinensis organic solvent extraction mixture input melt cinder is extracted segregation apparatus, separates slag charge, carry out expression separation by 20 ~ 100kg/h, obtain Fructus Tonnae Sinensis extract ORGANIC SOLVENT MIXTURES.
Wherein, described organic solvent is ethyl acetate.
(
4
) concentrating under reduced pressure
By in Fructus Tonnae Sinensis extract ORGANIC SOLVENT MIXTURES input dynamic circulation low-temperature evaporation concentrator, it is depressurized to 0.08 ~ 0.1MPa, maintains the temperature at 20 ~ 40 DEG C, evaporation and concentration；
Collect concentrated extract, be dried and make water content be less than or equal to 3%, obtain Fructus Tonnae Sinensis extract.
Following embodiment 5~ Embodiment 10 It is to embodiment 4 The optimization of described Fructus Tonnae Sinensis method for preparing extractive, it may be assumed thatUse the preparation method of the Fructus Tonnae Sinensis extract of embodiment 4, only change (3) continuous flow upstream tubular ultrasonic extraction step, speed, the reverse flow velocity of organic solvent and the supersound extraction pipe temperature of Fructus Tonnae Sinensis superfine powder is done multiplicity, and the content using conventional method that the Fructus Tonnae Sinensis extract extracted is carried out every concrete material is measured.
The multiplicity (embodiment 5 ~ embodiment 10) of the speed of table 1 Fructus Tonnae Sinensis superfine powder, the reverse flow velocity of organic solvent and supersound extraction pipe temperature
The every concrete content of material measurement result of table 2 Fructus Tonnae Sinensis of the present invention extract (embodiment 4 ~ embodiment 10)
Being tested from above-mentioned multiplicity, embodiment 7 ~ embodiment 8 is preferred embodiment, i.e. the charging rate 2 ~ 2.5kg/min of Fructus Tonnae Sinensis superfine powder, organic solvent reverse flow velocity 9 ~ 10L/min and supersound extraction pipe temperature 70 ~ 75 DEG C.
Embodiment
11
A kind of preparation method of the plant salt containing Fructus Tonnae Sinensis extract
Comprise the following steps:
One, the preparation of Fructus Tonnae Sinensis extract
Use the preparation method of the Fructus Tonnae Sinensis extract of embodiment 4, only change (3) continuous flow upstream tubular ultrasonic extraction step, speed, the reverse flow velocity of organic solvent and three factors of supersound extraction pipe temperature to Fructus Tonnae Sinensis superfine powder, change into the charging rate 2 ~ 2.5kg/min of Fructus Tonnae Sinensis superfine powder, organic solvent reverse flow velocity 9 ~ 10L/min and supersound extraction pipe temperature 70 ~ 75 DEG C, obtain Fructus Tonnae Sinensis extract.
Two, the extraction of Suaeda salsa plant salt
(
1
) enzymolysis process
By Herba suadeae glaucae break process, it is that 1:10～1:20 mix with water according to mass ratio by broken Herba suadeae glaucae, regulation pH to 5.5～7.5, in Herba suadeae glaucae mass ratio 3～the ratio addition α-amylase of 5%, enzymolysis under ultrasonic assistant effect, hydrolysis temperature 70～80 DEG C, ultrasonic power 300W, period uses blender at the uniform velocity to stir, and the time is about 10～20min；
Enzymolysis filters after terminating, and takes filtrate；Adjusting the pH to 8.0～9.0 of filtrate, in Herba suadeae glaucae mass ratio 2～the ratio addition alkaline protease of 3%, enzymolysis under ultrasonic assistant effect, hydrolysis temperature 50～60 DEG C, ultrasonic power 300W, period employing blender at the uniform velocity stirs, and enzymolysis time is 60～90min；
Enzymolysis terminates rear enzyme denaturing, filters, takes filtrate；
(
2
) removing heavy-metal
Adding biological adsorption agent in described filtrate, addition is the 0.2～0.6% of extracting solution quality, and extracting solution temperature controls at 36～40 DEG C, and 90rpm stirs 20～24 hours；
Crystallized, pulverize dried, obtain Suaeda salsa plant salt.
Described biological adsorption agent includes chitosan 8～10 parts, Algin 4～5 parts, microorganism formulation 2～3 parts；
Described microorganism formulation includes bread mold 5 × 108Individual/g, white rot shield shell mould 2 × 108Individual/g, Aureobasidium pullulans 3 × 108Individual/g, Pichia sp. 7 × 108Individual/g；
Described bread mold ( Rhizopusnigricans ) culture presevation number isACCC31509；White rot shield shell mould ( Coniothyriumdiplodiella ) culture presevation number isACCC36140；Aureobasidium pullulans ( Aureobasidiumpullulans ) culture presevation number isCICC40333；Pichia sp. ( Pichiasp. ) culture presevation number isACCC21015；
Above-mentioned strain is all from commercially available.
Three, weigh
Fructus Tonnae Sinensis extract and Suaeda salsa plant salt is weighed according to formula.
Four, mixing
By the Fructus Tonnae Sinensis extract weighed and the stirring of Suaeda salsa plant salt, mix homogeneously, make mixed-powder, the plant salt of Fructus Tonnae Sinensis extract must be contained.
Application effect:
1
, the present invention containing Fructus Tonnae Sinensis extract plant salt Local irritation study test and effect
Take healthy adult SD rat 48, body weight (200 scholar 20) g, male and female half and half, be randomly divided into blank group, group of solvents, 1 group ~ embodiment of the embodiment of the present invention 3 groups, phinamide group, often group 8.Fasting about 12h before test, 1 group ~ embodiment of the embodiment of the present invention 3 groups gives rats with bilateral nasal cavity collunarium for the solution that the plant salt containing Fructus Tonnae Sinensis extract described in the embodiment of the present invention 1 ~ embodiment 3 is made into 1mg/ml with 1.5ml/kgbw；Group of solvents, phinamide group give the phinamide solution of the distilled water of 1.5ml/kgbw, 1.5ml/kgbw with method, and blank group does not make any process.After observation is administered in detail, the response situation of animal in 4h, records animal response situation in 4h, including the outward appearance of animal, behavioral activity, the mental status, two just and color, breath state, and nose, eye, oral cavity are with or without abnormal secretion thing, body weight change, the initial time of toxic reaction, the order of severity etc..
Each situation of change organizing rat body weight in table 3 Local irritation study
Histopathological examination: after experiment, the respiratory mucosas such as the Mus nose of rat, larynx, trachea-bronchial epithelial cell are carried out pathology cut sections for microscopic examination, each group is showed no significantly damage change and a large amount of cell infiltration, compare with blank group, there is no significant difference, being indicated above the plant salt local application containing Fructus Tonnae Sinensis extract of 1 group ~ embodiment of embodiments of the invention 3 groups without obvious irritation, its Clinical practice is safer.
Conclusion: the present invention contains the plant salt of Fructus Tonnae Sinensis extract to experimental animal without obvious local irritation.
, the present invention plant salt containing Fructus Tonnae Sinensis extract is to treating migrainous test and effect
2.1 physical data
Select migraineur 360 example, case selection meets in the migrainous classification of International Headache association in 2004 and diagnosis Migraine without aura and has the migrainous diagnostic criteria of tendency type (get rid of: the headache caused by organic disease, cervical spondylosis, infectious disease such as hypertension, cerebrovas-cularaccident, the cerebral tumor, anemia of pregnant woman, bleeding and clotting obstacle person).
Selected patient is randomly divided into 4 groups, 1 group ~ embodiment of embodiment 3 groups and matched group, often organize 90 examples, male 45 example, women 45 example, age 25～55 years old, average (33.54 ± 9.12) year.Two groups of physical data compare, the equal not statistically significant of difference, have comparability.VAS scoring and attack times before treatment there was no significant difference.
2.2 Therapeutic Method
1 group ~ embodiment of embodiment 3 groups selects the plant salt containing Fructus Tonnae Sinensis extract described in embodiment 1 ~ embodiment 3,10mg/d, once a day, takes 4 weeks continuously；Matched group gives general treatment, oral hydrochloride flunarizine capsule, 5mg/d, once a day, takes 4 weeks continuously.
2.3 criterion of therapeutical effect
Criterion of therapeutical effect is drafted with reference to Ministry of Health of the People's Republic of China's " new Chinese medicine guideline of clinical investigations " and " neurological ".Clinical recovery: headache and simultaneous phenomenon disappear；Effective: pain intensity and simultaneous phenomenon substantially alleviate, attack times reduces, and the persistent period reduces more than 2/3；Effective: headache has alleviated, outbreak extends interval time, and the persistent period reduces more than 1/3；Invalid: pain is without obvious change or increases the weight of, attack times increases, duration extension.
2.4 clinical observation on the therapeutic effect interpretations of result
According to above-mentioned Therapeutic Method, and detect the therapeutic effect of each group, as shown in table 4 below,
Table 41 group ~ embodiment of the embodiment of the present invention 3 groups and matched group Clinical efficacy comparison
The effective percentage of 1 group ~ embodiment of the embodiment of the present invention 3 groups is 91.11 ~ 94.44%, and the effective percentage of matched group is 57.58%, and result proves, 3 groups of effective percentage of 1 group ~ embodiment of the embodiment of the present invention are apparently higher than matched group.
Except as otherwise noted, the percent employed in the present invention is percetage by weight, ratio of the present invention, is mass ratio.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, it is not limited to the present invention, although the present invention being described in detail with reference to previous embodiment, for a person skilled in the art, technical scheme described in foregoing embodiments still can be modified by it, or wherein portion of techniques feature is carried out equivalent.All within the spirit and principles in the present invention, any modification, equivalent substitution and improvement etc. made, should be included within the scope of the present invention.
Claims (10)
1. the plant salt containing Fructus Tonnae Sinensis extract, it is characterised in that described plant salt, raw material includes Fructus Tonnae Sinensis extract and Suaeda salsa plant salt.
A kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 1, it is characterised in that include the raw material of following weight portion: Fructus Tonnae Sinensis extract 2 ~ 4 parts, Suaeda salsa plant salt 6 ~ 8 parts.
A kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 1, it is characterised in that described Fructus Tonnae Sinensis extract, Fructus Tonnae Sinensis general flavone content is 0.53 ~ 0.61mg/g, and gallic acid content is 0.42 ~ 0.53mg/g.
A kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 1, it is characterised in that described Suaeda salsa plant salt, general flavone content be 2.6 ~ 2.7mg/g, Fe content be 690 ~ 700mg/kg.
5. the preparation method of the plant salt containing Fructus Tonnae Sinensis extract, it is characterized in that, the preparation of described Fructus Tonnae Sinensis extract includes continuous flow upstream tubular ultrasonic extraction step, described continuous flow upstream tubular ultrasonic extraction step, the charging rate 0.5 ~ 3.5kg/min of Fructus Tonnae Sinensis superfine powder.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 5, it is characterized in that, the preparation of described Fructus Tonnae Sinensis extract includes continuous flow upstream tubular ultrasonic extraction step, described continuous flow upstream tubular ultrasonic extraction step, organic solvent reverse flow velocity 6 ~ 12L/min.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 5, it is characterised in that supersound extraction pipe temperature 55 ~ 85 DEG C.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 5, it is characterized in that, the preparation of described Fructus Tonnae Sinensis extract also includes breaking cellular wall step, described breaking cellular wall step, under vacuum is-0.073MPa～-0.08MPa, microwave treatment 10～30min.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 5, it is characterised in that the preparation of described Fructus Tonnae Sinensis extract also includes concentrating under reduced pressure step, described concentrating under reduced pressure step, decompressed pressure is 0.08 ~ 0.1MPa.
The preparation method of a kind of plant salt containing Fructus Tonnae Sinensis extract the most according to claim 5, it is characterized in that, Suaeda salsa plant salt extraction step includes enzymolysis process, described enzymolysis process, in Herba suadeae glaucae mass ratio 3～the ratio addition α-amylase of 5%, hydrolysis temperature 70～80 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610294008.2A CN105919025A (en) | 2016-05-03 | 2016-05-03 | Vegetable salt containing Chinese mahogany seed extract and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610294008.2A CN105919025A (en) | 2016-05-03 | 2016-05-03 | Vegetable salt containing Chinese mahogany seed extract and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105919025A true CN105919025A (en) | 2016-09-07 |
Family
ID=56835146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610294008.2A Withdrawn CN105919025A (en) | 2016-05-03 | 2016-05-03 | Vegetable salt containing Chinese mahogany seed extract and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105919025A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109464499A (en) * | 2018-11-02 | 2019-03-15 | 阜阳师范学院 | A kind of medical composition and its use |
| CN109481503A (en) * | 2018-11-02 | 2019-03-19 | 阜阳师范学院 | A kind of purposes of Chinese toon extract |
| CN109481502A (en) * | 2018-11-02 | 2019-03-19 | 阜阳师范学院 | A kind of preparation method of Chinese toon extract |
| CN115006447A (en) * | 2022-06-09 | 2022-09-06 | 三峡大学 | Pharmaceutical application of cedrela sinensis seed polyphenol |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1107666A (en) * | 1994-03-17 | 1995-09-06 | 王跃进 | Health edible salt |
| CN102551028A (en) * | 2012-03-01 | 2012-07-11 | 山东凯尔海洋生物科技有限公司 | Method for preparing suaeda salsa biogenetic salt |
| CN104996115A (en) * | 2015-06-23 | 2015-10-28 | 潍坊友容实业有限公司 | Method for planting suaeda salsa at medium-low-cadmium saline-alkaline land and for extracting plant salt |
| CN105037375A (en) * | 2015-07-30 | 2015-11-11 | 潍坊友容实业有限公司 | Method for extracting chlorophyll and preparing plant-salt through comprehensive utilization of suaeda salsa |
| CN105343180A (en) * | 2015-11-13 | 2016-02-24 | 潍坊医学院 | Extracting method of Chinese toon seed polyphenols and uses of the polyphenols for treating Parkinson disease |
-
2016
- 2016-05-03 CN CN201610294008.2A patent/CN105919025A/en not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1107666A (en) * | 1994-03-17 | 1995-09-06 | 王跃进 | Health edible salt |
| CN102551028A (en) * | 2012-03-01 | 2012-07-11 | 山东凯尔海洋生物科技有限公司 | Method for preparing suaeda salsa biogenetic salt |
| CN104996115A (en) * | 2015-06-23 | 2015-10-28 | 潍坊友容实业有限公司 | Method for planting suaeda salsa at medium-low-cadmium saline-alkaline land and for extracting plant salt |
| CN105037375A (en) * | 2015-07-30 | 2015-11-11 | 潍坊友容实业有限公司 | Method for extracting chlorophyll and preparing plant-salt through comprehensive utilization of suaeda salsa |
| CN105343180A (en) * | 2015-11-13 | 2016-02-24 | 潍坊医学院 | Extracting method of Chinese toon seed polyphenols and uses of the polyphenols for treating Parkinson disease |
Non-Patent Citations (1)
| Title |
|---|
| 王振宇 等: "《植物资源学》", 31 January 2007, 北京：中国科学技术出版社 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109464499A (en) * | 2018-11-02 | 2019-03-15 | 阜阳师范学院 | A kind of medical composition and its use |
| CN109481503A (en) * | 2018-11-02 | 2019-03-19 | 阜阳师范学院 | A kind of purposes of Chinese toon extract |
| CN109481502A (en) * | 2018-11-02 | 2019-03-19 | 阜阳师范学院 | A kind of preparation method of Chinese toon extract |
| CN109481502B (en) * | 2018-11-02 | 2021-08-03 | 阜阳师范学院 | Preparation method of cedrela sinensis extract |
| CN109481503B (en) * | 2018-11-02 | 2021-08-03 | 阜阳师范学院 | Application of Chinese toon extract |
| CN109464499B (en) * | 2018-11-02 | 2021-10-29 | 阜阳师范学院 | Pharmaceutical composition and application thereof |
| CN115006447A (en) * | 2022-06-09 | 2022-09-06 | 三峡大学 | Pharmaceutical application of cedrela sinensis seed polyphenol |
| CN115006447B (en) * | 2022-06-09 | 2023-08-25 | 三峡大学 | Pharmaceutical application of Toonae sinensis seed polyphenol |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104844723B (en) | A kind of preparation method and application of Herba Dendrobii extract | |
| CN113150867B (en) | Preparation method of ganoderma lucidum extract oil rich in ganoderma lucidum triterpenes | |
| CN105919025A (en) | Vegetable salt containing Chinese mahogany seed extract and preparation method thereof | |
| CN102101884A (en) | Preparation method and use of donkey-hide gelatin polypeptide | |
| CN112972586A (en) | Chinese herbal medicine composition preparation for treating hyperuricemia through fermentation of myxomycete and preparation method | |
| CN112587648A (en) | Bitter gourd peptide composition for preventing and treating diabetes and preparation method thereof | |
| CN109718273B (en) | Application of perilla leaf extract in preventing or treating osteoarthritis | |
| CN106822579B (en) | Composition with osteoporosis treatment effect and preparation method and application thereof | |
| CN1733081A (en) | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process | |
| CN1895498A (en) | Health-care bee products mixed with Chinese medicines | |
| CN105852033A (en) | Plant salt containing pagodatree flower bud extracts and preparation method of plant salt | |
| CN105998192A (en) | Application of industrial cannabinoid in preparing drugs for treating gouty arthritis | |
| CN100444849C (en) | New use of tribulus terrestris extraction | |
| CN108785358A (en) | A kind of preparation method of Honegsukle flower P.E | |
| CN104435072B (en) | A kind of extract and preparation method thereof with auxiliary hyperglycemic, reducing blood lipid | |
| CN106728373A (en) | Poria cocos glossy ganoderma and honey oral liquid | |
| CN107056959A (en) | Jerusalem artichoke moderate resistance HSV 1, the composition of RSV, EV 71 and preparation | |
| CN106165898A (en) | There is health composition of increase bone density, easing joint movement and preparation method thereof | |
| KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
| CN103461603A (en) | Food blood-nourishing tea granule for improving alimentary anemia | |
| CN105412414B (en) | Japanese leech composition for skin care and preparation method thereof | |
| CN116036174B (en) | Medicine for treating pulmonary nodules and preparation method thereof | |
| CN109674854A (en) | A kind of shield pharynx treasure pill and preparation method thereof | |
| KR20200027308A (en) | Method for manufacturing Aquilaria agallocha Roxburgh Gongnokdan | |
| CN109568376B (en) | Anti-aging traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160907 |